ED After 50: How Aging Changes Erectile Function and What to Do About It

If you're over 50 and dealing with ED, the first thing to understand is that you're in the majority — not the minority. The prevalence of erectile dysfunction rises sharply with age: roughly 40% at age 40, 50% at age 50, and upward from there. By 70, more men have some degree of ED than don't.

But here's what too many men get wrong: they assume it's just what happens when you get older, shrug it off, and don't seek treatment. That's a mistake for two reasons. First, ED at this age is highly treatable — response rates to medication are strong even in older men. Second, new-onset ED after 50 can be an early warning sign of cardiovascular disease, and ignoring it means ignoring a signal your body is giving you.

Is ED After 50 "Normal"?

It's common, but "normal" is a loaded word. Age is the single biggest risk factor for ED, and the prevalence curve steepens sharply after 50. But saying ED is normal after 50 is like saying high blood pressure is normal after 50 — it's statistically frequent, it has identifiable causes, and it's treatable. You wouldn't ignore rising blood pressure because "it's just aging." The same logic applies here.

The increased prevalence at this age is driven by several converging factors: accumulated vascular damage from decades of lifestyle and genetic risk factors, declining testosterone (total testosterone drops roughly 1–2% per year after 30), the accumulation of medications that affect sexual function, and the progression of conditions like diabetes, hypertension, and metabolic syndrome.

The key distinction is between age-related changes (which are real) and untreatable decline (which is mostly a myth). Yes, erections at 55 are different from erections at 25 — they may take longer to achieve, require more direct stimulation, and the refractory period is longer. But the ability to achieve satisfying sexual function should not disappear, and when it does, treatment works.

How Aging Changes Erectile Function

Understanding the specific mechanisms helps set realistic expectations and guide treatment decisions.

Vascular changes

This is the primary driver. Over decades, the endothelium (the lining of blood vessels) accumulates damage from oxidative stress, inflammation, and the usual suspects — hypertension, elevated cholesterol, smoking, diabetes. The penile arteries are among the smallest in the body (1–2mm diameter), so they show damage before larger vessels like the coronary arteries. This is why ED often precedes heart disease by 3–5 years.

Hormonal decline

Total testosterone decreases by approximately 1–2% per year after age 30, and SHBG (the protein that binds testosterone, making it unavailable) increases with age. The net result is a gradual decline in free (bioavailable) testosterone. By 50, many men have measurably lower testosterone than they did at 30, though most remain within the "normal" range.

As covered in our testosterone and ED article, low testosterone primarily affects libido rather than mechanical function — but at this age, it often co-occurs with vascular ED, creating a two-front problem.

Neurological changes

Nerve conduction slows with age, and conditions like diabetes accelerate this process through peripheral neuropathy. The nerves that signal penile blood vessel dilation become less responsive. This manifests as needing more stimulation and more time to achieve full erection.

Structural changes

The smooth muscle tissue in the penis gradually decreases with age and is replaced by collagen/fibrotic tissue. This reduces the expansibility of the erectile chambers. The process is accelerated by conditions that cause chronic low-level inflammation.

The Polypharmacy Problem

This is one of the most underappreciated causes of ED in men over 50. The average man in his 60s takes five or more prescription medications. Many of these can cause or worsen ED — and when you're taking several, the combined effect can be significant.

The challenge is that many of these medications treat conditions that also cause ED independently (hypertension, depression, BPH). Untangling whether the condition or the medication is the primary culprit — or whether it's both — requires careful evaluation. A good provider will review your entire medication list as part of the ED workup.

For a deeper dive into this topic, see our dedicated article on medications that cause ED.

ED as a Cardiovascular Early Warning

This deserves emphasis because it's genuinely life-saving information. New-onset ED in men aged 50–70 who don't have other obvious causes (new medications, major psychological stress, injury) should be treated as a cardiovascular screening opportunity.

The evidence is robust: the penile arteries are significantly smaller than coronary arteries, so atherosclerotic damage shows up there first. Multiple studies have demonstrated that ED precedes coronary artery disease symptoms by an average of 3–5 years. Men with ED and no known heart disease have roughly double the risk of a cardiac event in the following decade compared to men without ED.

This doesn't mean ED equals heart disease — most men with ED don't have a heart attack. But it means that treating the ED while also getting a basic cardiovascular workup (blood pressure, lipid panel, fasting glucose, possibly a stress test if risk factors are present) is the responsible approach.

For the full picture on this connection, see our article on ED as a cardiovascular warning sign.

Why Daily Tadalafil Is Often the Best First Move After 50

All PDE5 inhibitors work for men over 50, but daily low-dose tadalafil (2.5–5mg) has several advantages that make it particularly well-suited for this age group.

Continuous coverage

Unlike on-demand sildenafil (which requires planning 30–60 minutes ahead), daily tadalafil maintains a steady level in your system. This means erections can happen spontaneously when the moment is right, without the "take a pill and wait" routine. For men in long-term relationships, this feels more natural and removes the performance pressure of timed medication.

BPH treatment in the same pill

Daily tadalafil 5mg is FDA-approved for both ED and benign prostatic hyperplasia (enlarged prostate). Most men over 50 have some degree of BPH — symptoms include frequent urination, weak stream, nighttime waking to urinate, and urgency. Treating both conditions with a single medication simplifies the regimen and reduces pill burden.

Lower side effect profile

The daily dose (2.5–5mg) is much lower than the on-demand dose (10–20mg), which typically means fewer side effects. The most common side effects — headache, flushing, nasal congestion — are less frequent at the lower daily dose. For men already taking multiple medications, minimizing additional side effects matters.

Cardiovascular benefits

Emerging research suggests that daily PDE5 inhibitor use may have protective cardiovascular effects through improved endothelial function. While this isn't yet a primary indication, it's a promising secondary benefit for men in this age group.

Realistic Expectations for Treatment

An honest conversation about expectations is important. ED treatment at 55 is effective, but the goals may be different from what a 25-year-old expects.

"Functional" is the right benchmark, not "perfect." Treatment should restore the ability to achieve and maintain erections sufficient for satisfying sexual activity. That might not mean the rock-hard, instant erections of your 20s — and that's fine. The erection needs to be firm enough and last long enough for satisfying intercourse. Most treated men achieve this.

Response rates by age: PDE5 inhibitors have roughly a 65–70% success rate in men over 50, compared to ~80% in younger men. The slightly lower rate reflects the more advanced vascular damage in this age group. But 65–70% is still a strong majority, and there are additional options for the 30% who don't respond adequately to first-line medication.

Direct stimulation usually matters more. At this age, the days of getting an erection from visual stimulation alone may be behind you. Physical touch and direct stimulation become more important for achieving and maintaining erections, even with medication. This is a physiological reality, not a failure of treatment.

The refractory period is longer. The time between orgasm and the ability to achieve another erection increases with age. Daily tadalafil doesn't change this — it improves erection quality, not recovery speed. Setting realistic expectations here prevents disappointment.

When Pills Aren't Enough

For the minority of men who don't respond adequately to PDE5 inhibitors, there are effective alternatives:

• Vacuum erection devices (VEDs): Non-invasive, no side effects, ~90% success rate. Particularly well-suited for older men because they work regardless of vascular status. The erection looks and feels slightly different (cooler, more firm at the base), but satisfaction rates are high among men who give them a fair trial.
• Penile injections (alprostadil or trimix): Self-injection directly into the penis produces erections in ~85% of men who don't respond to oral medication. The injection is less painful than it sounds — most men describe it as a mild pinch. Commonly prescribed for post-prostatectomy ED or severe vascular ED.
• Penile implants: For men who've exhausted other options, inflatable penile implants have the highest satisfaction rate of any ED treatment (>90% patient and partner satisfaction). They're a surgical procedure with associated risks, but for men who are good candidates, outcomes are consistently positive.

The point is that there's always a next step. Men over 50 who don't respond to pills are not out of options — they're just ready for a different approach.

Online Providers for Men Over 50

Telehealth platforms are a good fit for men in this age group — they're private, convenient, and often cheaper than traditional urology visits. The key is choosing one that takes a thorough approach to screening, not just a quick prescription mill.

For a comprehensive comparison including pricing, medication options, and honest evaluations, see our complete 2026 provider ranking.